ACS Omega
(Nov 2023)
Targeting the Expanded TCF4/Fuchs’ Endothelial Corneal Dystrophy CUG Repeat with Morpholino Peptide Conjugates
- Jiaxin Hu,
- Xiulong Shen,
- Mahboubeh Kheirabadi,
- Matthew D. Streeter,
- Ziqing Qian,
- V. Vinod Mootha,
- David R. Corey
Affiliations
- Jiaxin Hu
- Department of Pharmacology and Biochemistry, UT Southwestern Medical Center, Dallas, Texas, United States
- Xiulong Shen
- Entrada Therapeutics Inc., Boston, Massachusetts, United States
- Mahboubeh Kheirabadi
- Entrada Therapeutics Inc., Boston, Massachusetts, United States
- Matthew D. Streeter
- Entrada Therapeutics Inc., Boston, Massachusetts, United States
- Ziqing Qian
- Entrada Therapeutics Inc., Boston, Massachusetts, United States
- V. Vinod Mootha
- Department of Ophthalmology, UT Southwestern Medical Center, Dallas, Texas, United States
- David R. Corey
- Department of Pharmacology and Biochemistry, UT Southwestern Medical Center, Dallas, Texas, United States
- DOI
-
https://doi.org/10.1021/acsomega.3c05634
- Journal volume & issue
-
Vol. 8,
no. 45
pp.
42797
– 42802
WeChat QR code